Neuropsychiatric Symptoms
9
2
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
Augmented Reality-Based Aromatherapy Education for Older Adults With Early-Stage Dementia in Taiwan
The Pain Reduction Using Immersive Virtual Reality During Wound Care Evaluation Study at Maimonides (PRISM) - Pilot Study
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Treatment for Social Cognition Disorders (T-ScEmo) in Patients With Acquired Brain Injury and Comorbid Neuropsychiatric Problems
Validation of the MBI-C Scale in French
Different Doses of Dexmedetomidine Combined With Esketamine in Women Undergoing Cesarean Delivery
Electro-acupuncture for Long Covid Neuropsychiatric Symptoms
Exploring Use of Companion Robot Pets for Older Adults in Care Homes